Humoral and Cellular Immunogenicity of the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Nursing Home Residents.

Van Praet, Jens T; Vandecasteele, Stefaan; De Roo, Anneleen; De Vriese, An S; Reynders, Marijke

Van Praet, Jens T; Vandecasteele, Stefaan; De Roo, Anneleen; De Vriese, An S; Reynders, Marijke.

Van Praet JT; Department of Nephrology and Infectious Diseases, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium.
Vandecasteele S; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
De Roo A; Department of Nephrology and Infectious Diseases, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium.
De Vriese AS; Curando, Ruiselede, Belgium.
Reynders M; Department of Nephrology and Infectious Diseases, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium.

Clin Infect Dis ; 73(11): 2145-2147, 2021 12 06.

Article in English | MEDLINE | ID: covidwho-1575339

Subject(s)

COVID-19 Vaccines; COVID-19; BNT162 Vaccine; Humans; Nursing Homes; RNA, Messenger; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: Cid

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google